UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Alibaba
BABA
|
+$624M |
| 2 |
Microsoft
MSFT
|
+$360M |
| 3 |
Accenture
ACN
|
+$249M |
| 4 |
Walmart
WMT
|
+$205M |
| 5 |
Mastercard
MA
|
+$198M |
Top Sells
| 1 |
Vanguard Total Stock Market ETF
VTI
|
+$329M |
| 2 |
CELG
Celgene Corp
CELG
|
+$293M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$220M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$188M |
| 5 |
JPMorgan Chase
JPM
|
+$173M |
Sector Composition
| 1 | Technology | 19.83% |
| 2 | Financials | 14.05% |
| 3 | Healthcare | 13.56% |
| 4 | Consumer Discretionary | 12.64% |
| 5 | Communication Services | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PGNX
2326
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $287K | ﹤0.01% |
56,462
-3,413
| -6% | -$17.4K |
|
2327
CytomX Therapeutics
CTMX
$341M
| $287K | ﹤0.01% |
34,583
-2,471
| -7% | -$20.5K |
|
2328
StoneX
SNEX
$5.16B
| $285K | ﹤0.01% |
13,136
+124
| +1% | +$2.69K |
|
|
RDUS
2329
DELISTED
Radius Recycling
RDUS
| $282K | ﹤0.01% |
12,985
+99
| +0.8% | +$2.15K |
|
|
PDS
2330
Precision Drilling
PDS
$744M
| $281K | ﹤0.01% |
10,062
+190
| +2% | +$5.3K |
|
|
BNFT
2331
DELISTED
Benefitfocus, Inc.
BNFT
| $278K | ﹤0.01% |
12,651
+1,150
| +10% | +$25.2K |
|
2332
HCI Group
HCI
$2.35B
| $275K | ﹤0.01% |
6,034
-935
| -13% | -$42.7K |
|
|
GMRE
2333
Global Medical REIT
GMRE
$514M
| $275K | ﹤0.01% |
+20,800
| New | +$275K |
|
|
BMY.RT
2334
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $275K | ﹤0.01% |
+91,261
| New | +$275K |
|
2335
Vital Energy
VTLE
$638M
| $274K | ﹤0.01% |
4,778
-591
| -11% | -$33.9K |
|
2336
Peapack-Gladstone Financial
PGC
$511M
| $274K | ﹤0.01% |
+8,868
| New | +$274K |
|
2337
TruBridge
TBRG
$305M
| $274K | ﹤0.01% |
+10,375
| New | +$274K |
|
2338
Cross Country Healthcare
CCRN
$419M
| $272K | ﹤0.01% |
+23,416
| New | +$272K |
|
2339
1st Source
SRCE
$1.57B
| $268K | ﹤0.01% |
5,175
+66
| +1% | +$3.42K |
|
2340
Vishay Precision Group
VPG
$410M
| $268K | ﹤0.01% |
+7,877
| New | +$268K |
|
2341
Heidrick & Struggles
HSII
$1.03B
| $267K | ﹤0.01% |
+8,208
| New | +$267K |
|
|
CUTR
2342
DELISTED
Cutera, Inc.
CUTR
| $267K | ﹤0.01% |
+7,445
| New | +$267K |
|
|
LTS
2343
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
| $266K | ﹤0.01% |
76,484
+26,944
| +54% | +$93.8K |
|
|
RST
2344
DELISTED
ROSETTA STONE INC
RST
| $265K | ﹤0.01% |
+14,586
| New | +$265K |
|
|
GNMK
2345
DELISTED
GenMark Diagnostics, Inc
GNMK
| $264K | ﹤0.01% |
54,974
-1,440
| -3% | -$6.93K |
|
2346
Tredegar Corp
TG
$276M
| $263K | ﹤0.01% |
+11,758
| New | +$263K |
|
|
CMBT
2347
CMB.TECH NV
CMBT
$2.72B
| $263K | ﹤0.01% |
20,952
-5,300
| -20% | -$66.5K |
|
2348
Resources Connection
RGP
$169M
| $261K | ﹤0.01% |
16,002
-2,396
| -13% | -$39.1K |
|
2349
Luxfer Holdings
LXFR
$361M
| $261K | ﹤0.01% |
14,100
+11,748
| +499% | +$217K |
|
2350
Park-Ohio Holdings
PKOH
$321M
| $261K | ﹤0.01% |
7,743
| – | – |
|